Skip to main content

Haleon plc (HLN) Stock Forecast

Data as of Sep 20, 2026

Healthcare · Current price $9.31 (-0.48%)

Consensus Target
$10.20
Upside
+9.5%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $10.20High $10.20

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

HLN vs Sector & Market

MetricHLNHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count1818
Target Upside+9.5%+22243.7%+21.5%
P/E Ratio30.643.7338.34

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$5.34B$5.36B$5.38B1
2027-03-31$5.32B$5.33B$5.36B1
2027-06-30$5.52B$5.54B$5.57B1
2027-09-30$5.23B$5.24B$5.27B1
2027-12-31$5.65B$5.67B$5.70B1
2028-03-31$5.72B$5.74B$5.77B1
2028-06-30$5.70B$5.72B$5.74B1
2028-09-30$2.86B$2.87B$2.88B1
2028-12-31$2.86B$2.87B$2.88B1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$0.17$0.17$0.171
2027-03-31$0.17$0.18$0.181
2027-06-30$0.17$0.17$0.171
2027-09-30$0.16$0.16$0.161
2027-12-31$0.18$0.19$0.191
2028-03-31$0.19$0.19$0.191
2028-06-30$0.21$0.21$0.211
2028-09-30$0.21$0.21$0.211
2028-12-31$0.21$0.21$0.211

Frequently Asked Questions

What is the analyst consensus for HLN?

The consensus among 1 analysts covering Haleon plc (HLN) is Buy with an average price target of $10.20.

What is the highest price target for HLN?

The highest analyst price target for HLN is $10.20.

What is the lowest price target for HLN?

The lowest analyst price target for HLN is $10.20.

How many analysts cover HLN?

1 analysts have issued ratings for Haleon plc in the past 12 months.

Is HLN a buy or sell right now?

Based on 1 analyst ratings, HLN has a consensus rating of Buy (2.00/5) with a +9.5% upside to the consensus target of $10.20.

What are the earnings estimates for HLN?

Analysts estimate HLN will report EPS of $0.17 for the period ending 2026-12-31, with revenue estimated at $5.36B.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.